Dimensional Fund Advisors LP Fate Therapeutics Inc Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,619,017 shares of FATE stock, worth $4.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,619,017
Previous 2,130,280 22.94%
Holding current value
$4.4 Million
Previous $6.99 Million 31.19%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$3.12 - $5.57 $1.52 Million - $2.72 Million
488,737 Added 22.94%
2,619,017 $9.17 Million
Q2 2024

Aug 09, 2024
BUY
$3.26 - $7.08 $3.48 Million - $7.56 Million
1,067,101 Added 100.37%
2,130,280 $6.99 Million
Q1 2024

May 10, 2024
BUY
$3.54 - $8.35 $2.63 Million - $6.2 Million
742,405 Added 231.44%
1,063,179 $7.8 Million
Q4 2023

Feb 07, 2024
SELL
$1.65 - $3.94 $650,718 - $1.55 Million
-394,375 Reduced 55.15%
320,774 $1.2 Million
Q3 2023

Nov 09, 2023
BUY
$2.02 - $5.04 $1.03 Million - $2.57 Million
510,423 Added 249.32%
715,149 $1.52 Million
Q2 2023

Aug 09, 2023
SELL
$4.76 - $6.59 $689,262 - $954,251
-144,803 Reduced 41.43%
204,726 $974,000
Q1 2023

May 12, 2023
SELL
$4.24 - $11.12 $856,225 - $2.25 Million
-201,940 Reduced 36.62%
349,529 $1.99 Million
Q4 2022

Feb 09, 2023
BUY
$9.86 - $23.83 $3.07 Million - $7.43 Million
311,787 Added 130.08%
551,469 $5.56 Million
Q3 2022

Nov 10, 2022
SELL
$21.04 - $36.06 $578,263 - $991,073
-27,484 Reduced 10.29%
239,682 $5.37 Million
Q2 2022

Aug 12, 2022
SELL
$17.78 - $42.39 $2.17 Million - $5.17 Million
-121,950 Reduced 31.34%
267,166 $6.62 Million
Q1 2022

May 13, 2022
SELL
$29.67 - $60.28 $752,460 - $1.53 Million
-25,361 Reduced 6.12%
389,116 $15.1 Million
Q4 2021

Feb 09, 2022
BUY
$47.84 - $64.34 $4.56 Million - $6.14 Million
95,408 Added 29.9%
414,477 $24.3 Million
Q3 2021

Nov 12, 2021
BUY
$59.27 - $95.73 $11.3 Million - $18.3 Million
191,004 Added 149.15%
319,069 $18.9 Million
Q2 2021

Aug 12, 2021
BUY
$67.25 - $92.52 $4.26 Million - $5.86 Million
63,303 Added 97.75%
128,065 $11.1 Million
Q1 2021

May 14, 2021
BUY
$72.16 - $117.4 $2.34 Million - $3.8 Million
32,404 Added 100.14%
64,762 $5.36 Million
Q4 2020

Feb 25, 2021
BUY
$38.09 - $100.95 $1.23 Million - $3.27 Million
32,358 New
32,358 $2.94 Million

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $163M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email